TimothyM.D.SterlingMD

Infectious Disease • Nashville, TN

Professor, Medicine, Vanderbilt University School of Medicine

Join to view full profile

Dr. Sterling is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sterling's full profile

Already have an account?

Office
3601 21st Ave S
Nashville, TN 37232
Phone+1 615-322-3000

Fax+1 615-936-0605

Education & Training

Johns Hopkins UniversityFellowship, Infectious Disease, 1996 - 1998
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1989 - 1992
Columbia University Vagelos College of Physicians and SurgeonsClass of 1989

Certifications & Licensure

TN State Medical License 2003 - 2025
MD State Medical License 1997 - 2003
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Clinical Trials

Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis Infection Start of enrollment: 2001 Jun 01
Completed
Phase 3
Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI Start of enrollment: 2019 Aug 01
Recruiting
Phase 2, Phase 3

Publications & Presentations

PubMed

Transcriptomic Signatures of Progression to Tuberculosis Disease Among Close Contacts in Brazil.
Simon C Mendelsohn, Bruno B Andrade, Stanley Kimbung Mbandi, Alice M S Andrade, Vanessa M Muwanga
The Journal of Infectious Diseases. 2024-12-16
Assessment for Antibodies to Rifapentine and Isoniazid in Persons Developing Flu-Like Reactions During Treatment of Latent Tuberculosis Infection.
Ruth N Moro, Carolina Mehaffy, Prithwiraj De, Elizabeth Phillips, Andrey S Borisov
The Journal of Infectious Diseases. 2024-11-15
Pharmacogenetics of tuberculosis treatment toxicity and effectiveness in a large Brazilian cohort.
Gustavo Amorim, James Jaworski, Jing Yang, Marcelo Cordeiro-Santos, Afrânio L Kritski
Pharmacogenetics and Genomics. 2024-10-15

Other

Treatment of pulmonary tuberculosis in HIV-negative patients
Sterling TR
http://www.uptodate.com/contents/treatment-of-pulmonary-tuberculosis-in-hiv-negative-patients
UpToDate, Wolters Kluwer Health - 2012-11-20
Treatment of pulmonary tuberculosis in the HIV-infected patient
Sterling TR
http://www.uptodate.com/contents/treatment-of-pulmonary-tuberculosis-in-the-hiv-infected-patient
UpToDate, Wolters Kluwer Health - 2013-01-22
Monitoring the HIV-infected patient on antituberculous medications
Sterling TR
http://www.uptodate.com/contents/monitoring-the-hiv-infected-patient-on-antituberculous-medications
UpToDate, Wolters Kluwer Health - 2012-09-28

Press Mentions

Validation Strategies Help Fill EHR Data GapsMay 2nd, 2024
Blood Test Figures in Cancer Risk for People with HIVMarch 17th, 2022
AIDS-Defining Events Increase Mortality Risk: StudyFebruary 9th, 2018
Join now to see all